Movement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure

Market Focus10:04

On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the biotechnology sector.

The biotech industry where CARsgen belongs experienced widespread weakness. Among sector constituents, Akeso dropped 8.94%, 3SBio fell 7.59%, SKBioscience declined 3.64%, Innovent Biologics shed 2.97%, and BeiGene retreated 2.36%. The broad-based nature of the decline suggests sector-level selling pressure rather than company-specific negative developments.

Notably, CARsgen had gained over 6% on July 15 and surged more than 7% on July 16 following positive clinical data showing its CAR-T therapy Satri-Cel demonstrated zero post-surgical recurrence or metastasis in a gastric cancer consolidation treatment trial accepted for poster presentation at ESMO, along with news that the product passed preliminary review for a commercial insurance innovative drug catalog. The current pullback appears to reflect profit-taking and sector rotation following the recent run-up.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156845057?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 10:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156845057","market":"us","top_or_hot":-1,"title":"Movement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure","media":"Market Focus","content":"<p><p>On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the biotechnology sector.</p><p>The biotech industry where CARsgen belongs experienced widespread weakness. Among sector constituents, Akeso dropped 8.94%, 3SBio fell 7.59%, SKBioscience declined 3.64%, Innovent Biologics shed 2.97%, and BeiGene retreated 2.36%. The broad-based nature of the decline suggests sector-level selling pressure rather than company-specific negative developments.</p><p>Notably, CARsgen had gained over 6% on July 15 and surged more than 7% on July 16 following positive clinical data showing its CAR-T therapy Satri-Cel demonstrated zero post-surgical recurrence or metastasis in a gastric cancer consolidation treatment trial accepted for poster presentation at ESMO, along with news that the product passed preliminary review for a commercial insurance innovative drug catalog. The current pullback appears to reflect profit-taking and sector rotation following the recent run-up.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-17 10:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the biotechnology sector.</p><p>The biotech industry where CARsgen belongs experienced widespread weakness. Among sector constituents, Akeso dropped 8.94%, 3SBio fell 7.59%, SKBioscience declined 3.64%, Innovent Biologics shed 2.97%, and BeiGene retreated 2.36%. The broad-based nature of the decline suggests sector-level selling pressure rather than company-specific negative developments.</p><p>Notably, CARsgen had gained over 6% on July 15 and surged more than 7% on July 16 following positive clinical data showing its CAR-T therapy Satri-Cel demonstrated zero post-surgical recurrence or metastasis in a gastric cancer consolidation treatment trial accepted for poster presentation at ESMO, along with news that the product passed preliminary review for a commercial insurance innovative drug catalog. The current pullback appears to reflect profit-taking and sector rotation following the recent run-up.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1156845057","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156845057","pubTimestamp":1784253884,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"走势提醒|CARsgen Therapeutics-B 常规交易中下跌 6.03%，生物技术板块面临广泛抛售压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the biotechnology sector.The biotech industry where CARsgen belongs experienced widespread weakness. Among sector constituents, Akeso dropped 8.94%, 3SBio fell 7.59%, SKBioscience declined 3.64%, Innovent Biologics shed 2.97%, and BeiGene retreated 2.36%. The broad-based nature of the decline suggests sector-level selling pressure rather than company-specific negative developments.Notably, CARsgen had gained over 6% on July 15 and surged more than 7% on July 16 following positive clinical data showing its CAR-T therapy Satri-Cel demonstrated zero post-surgical recurrence or metastasis in a gastric cancer consolidation treatment trial accepted for poster presentation at ESMO, along with news that the product passed preliminary review for a commercial insurance innovative drug catalog. The current pullback appears to reflect profit-taking and sector rotation following the recent run-up.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156845057","isCrawlerRequest":true}